Ocular Therapeutix Inc (NASDAQ:OCUL) currently has a daily average trading volume of 2.15M but it saw 2729792 shares traded in last market. With a market cap of 1.77B USD, the company’s current market price of $11.08 came rising about 2.97 while comparing to the previous closing price of $10.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.77 and as low as $5.78. In the recent trading on the day, stock has struck highest price mark of $10.61 while lowest mark touched by it was $11.2399.
Needham also issued its recommendations for the stock as it initiated the price target for the stock is $15.
Over the week, OCUL’s stock price is moving 17.12% up while it is 24.49% when we observe its performance for the past one month. Year-to-date it is 66.37% up and over the past year, the stock is showing an upside performance of 29.74%.
The company is expected to be releasing its next quarterly report on 2025-May-05, for which analysts forecasted an EPS of -0.35 while estimate for next year EPS is -1.45. In next quarter, company is expected to be making quarterly sales of $14.49M as analysts are expecting the sales for current fiscal year at $55.09M and seeing the company making $66.51M in sales next year. Moreover, analysts are in estimates of $13.12M for current-quarter revenue.
Currently, Ocular Therapeutix Inc’s total number of outstanding shares is 159.26M with 3.82% of that held by the insiders while 87.01% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -56.68% and return on equity (ROE) at -57.19%. Stock’s beta reads 1.48. Stock has a price to book (P/B) ratio of 6.64 while price to sale or P/S ratio amounts to 29.59. Its return on asset (ROA) is -40.79% on average.